Impact of Topical Phytotherapeutic Effects on Elevated Level of Serum Creatine Kinase- Muscle as Risk Factor of muscular degeneration in Knee-Osteoarthritis: Part III. A Systematic Meta-Analysis
DOI:
https://doi.org/10.21276/ztmtvy16Keywords:
Topical Phytotherapy, Knee-osteoarthritis, Phytoextracts, Medicinal plants, Knee- symmetry, creatine phosphokinase-muscle levelAbstract
Background: The knee-osteoarthritis (KOA) is a risk for muscular degeneration by the elevation of creatine kinase-muscle (CK-MM). The present study was aiming to normalize the elevated level of CK-MM by topical phytotherapeutic protocol correlated with anatomical measurements, the Kellgren- Lawrence (KL) grading systems of radiographic KOA, body mass index (BMI), overall improvement of pain under visual analogue scale (VAS) and pain, stiffness and physical function under WOMAC index. Methods: Baseline data from 108 patients (66.67 % females) with KOA aged 40-75 years old were recruited in this cross-sectional study. Bilateral anatomical measurements included the gap at the knee between the short head of the biceps femoris and the surface of the bed, diameter of muscles of thighs and calves, angles of straight leg raising, flexion and extension in different positions and BMI were measured using appropriate instruments. The elevated level of CK-MM, scored KL grading system and pain under VAS and WOMAC index were also evaluated at the baseline and after 42 days of treatment. Results: All the bilateral leg anatomical measurements were symmetry at the end of the 42nd session (P<0.0001). The significant changes were observed in VAS (P<0.00001), WOMAC index (P<0.0001), CK-MM level (P<0.0001), BMI (P<0.0001) and improvement of KL grading scores. Conclusions: The improvements of damaged leg muscles due to muscular dystrophy, connective tissue damage etc. confirmed with normalization of elevated serum CK-MM level, above mentioned anatomical measurements, BMI, VAS, WOMAC index and KL grading systems may be synergistic effect of phytochemicals during specific phytotherapeutic treatment protocol.
Downloads
References
Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiologic Reviews. 1988;10:1-28.
Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115-2126.
Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol. 2014;28: 5-15.
Mabey T, Honsawek S. Role of vitamin D in osteoarthritis: Molecular, cellular, and clinical perspectives, Int. J. Endocrinol. 2015;2015 (http://dx.doi.org/10.1155/2015/383918).
Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis. 2001;60:619- 626.
Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study, Ann. Rheum. Dis. 73 (2014) 1323-1330.
Thomson WHS, Leyburn P, Walton JN. Serum enzyme activity in muscular dystrophy. Br Med J. 1960;2(5208):1276-1281.
Otterness IG, Swindell AC, Zimmerer RO, Poole AR, Ionescu M, Weiner E. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline, Osteoarthr Cartil. 2000;8:180-185.
Ganguly A. Degenerative changes in lumbar region always lead to bilateral degenerative changes in knee-joints and vice-versa: Sensation of pain cannot only be the parameter of degeneration. Anat Physol. 2015a;S4-005 (doi:10/41722161-0940.S4-005). GangulyA.Degenerativechangesinlumbar-regionoccursimultaneously with bilateral-osteoarthritic changes in knee-joints and vice versa: Normalization with topical application of phytoconstiuents by specialized techniques involving possible cartilage-regeneration. Int J Recent Sci Res. 2015b;6(9):6331-6346.
A. Ganguly, Obtaining normal flexion and extension of knee joints on supine, prone and standing positions in osteoarthritis by topical phytotherapeutic treatment irrespective of age and sex. International Journal of Phytomedicine. 2015c;7(3):290-301. LaureysM,SionJ-P,SlabbynckH,etal.Macromolecularcreatinekinase type 1: A serum marker associated with disease. Clin Chem. 1991;37:430-434.
Galarraga B, Sinclair D, Fahie-Wilson MN, Mccrae FC, Hull RG, Ledingham JM. A rare but important cause for a raised serum creatine kinase concentration: two case reports and a literature review. Rheumatology. 2003;42:186-188. Tietz.TextbookofclinicalchemistandmolecularDiagnostic.(eds.Burtis, CA, Ashwood AR, Burns, DE), 5th editon, Elsevier Saunders; 2012. Ganguly A. Tropical phytotherapeutic treatment for achieving knee symmetry in osteoarthritis – A sustainable approach. International Journal of Phytomedicine. 2014;6(4): 489-509.
Ganguly A. Diagnosis, Prevention & Phytotherapy for Osteoarthritic Disorders, (ISBN: 978-3-330-65274-3), Scholars Press Book 2017; pp:13,14,46-48.
Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967;69:696-705. AppleFS,RogersMA,IvyJL.CreatinekinaseisoenzymeMMvariantsin skeletal muscle and plasma from marathon runners. Clin Chem. 1986;32:41-44.
Clarkeon PM, Apple FS, Byrnes WC, McCormick KM, Triffletti P. Creatinekinase isoforms following isometric exercise. Muscle Nerve. 1987;10:41-44.
Apple FS, Hellsten Y, Ciarkson, PM. Early detection of skeletal muscle injury by assay of creatinekinaseMM Isoformsin Serum. Clin Chem. 1988;34(6):1102-1104.
Parsons S, Alesci S, Feuerstein G, Wang J. Biomarkers in the development of novel disease-modifying therapies for osteoarthritis. Biomarkers Med. 2008;2(6):587-602.
Liu J, Shikhman AR, Lotz MK, Wong C-H. Hexosaminidase inhibitors as new drug candidates for the therapy of osteoarthritis. Chem. Biol. 2001;8(7):701-711.
Chantia A. Traditional Knowledge of ethno medicine in Jaunsarbawar, Dehradun district. Indian J. Tradit. Know. 2003;2(4):397-399.
Haslam E. Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J. Nat. Prod. 1996;59:205-215.
Kurian JC. Ethno-medicinal plants of India, Thailand and Vietnam. J. Biodiversity 2012; 3(1):61-75.
Singh GB, Atal CK. Pharmacology of an extract of salaiguggal ex- Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 1986;18:407-412.
Wang Q, Pan X, Wong HH, Wagner CA, Lahey LJ, Robinson WH, et al. Oral and topical boswellic acid attenuates mouse osteoarthritis. Osteoarthr. Cartil. 2014;22(1):128-132.
Belcaro G, Dugall M, Luzzi R, Hosoi M, Ledda A, Feragalli B, et al. PHYTOPROFLEX: supplementary management of osteoarthritis: a pilot, open, supplement registry. Medinova Medica 2017 (in press).
American Academy of Orthopaedic Surgeons (AAOS). Joint motion: method of measuring and recording. 4th reprint, E. & S. Livingstone Ltd., Edinburgh, 1965.
Cabaniss C. In Clinical Methods: The History, Physical, and Laboratory Examinations (eds. Walker H, Hall W, Hurst J.), 3rd edition, Butterworths, Boston 1990; 161-163. ScottJ,HuskissonEC.Graphicrepresentationofpain.Pain1976;2:175- 184. HaefeliM,ElferingA.Painassessment.EurSpineJ.2006;15:S17-S24. BellamyN,BuchnanWW,GoldsmithCH,CampbellJ,StittLW.Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to anti-rheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol.1988;15:1833- 1840. KellgrenJH,LawrenceJS.Rheumatisminminers.II.X-raystudy.BrJind Med. 1952;197-207.
Ganguly A. Obtaining normal flexion and extension of knee joints on supine, prone and standing positions in osteoarthritis by topical phytotherapeutic treatment irrespective of age and sex. International Journal of Phytomedicine. 2015d;7(3):290-301.
Gonçalves FB, Rocha FA, Albuquerque RP, Mozella A de P, Crespo B, Cobra H. Reproducibility assessment of different descriptions of the Kellgren and Lawrence classification for osteoarthritis of the knee. RevistaBrasileira de Ortopedia. 2016;51(6):687-691.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.
